The signaling effects of incremental information : evidence from stacked US Food and Drug Administration designations
Year of publication: |
2018
|
---|---|
Authors: | Miller, Kathleen L. ; Nardinelli, Clark ; Pink, George H. ; Reiter, Kristin |
Published in: |
The quarterly review of economics and finance : journal of the Midwest Economics Association ; journal of the Midwest Finance Association. - Amsterdam [u.a.] : Elsevier, ISSN 1062-9769, ZDB-ID 1114217-0. - Vol. 67.2018, p. 219-226
|
Subject: | Event study | FDA | Incremental information | Market model | Pharmaceuticals | Signaling | Arzneimittel | USA | United States | Signalling | Pharmaindustrie | Pharmaceutical industry | Ankündigungseffekt | Announcement effect | Arzneimittelrecht | Pharmaceutical law | Asymmetrische Information | Asymmetric information | Ereignisstudie | Börsenkurs | Share price | Informationswert | Information value |
-
FDA approval announcements : attention-grabbing or event-day misspecification?
Hamill, Philip A., (2018)
-
Competition in the pharmaceutical industry : the case of PAH drugs
Green, Kevin C., (2009)
-
The effects of drug safety warnings on drug sales and share prices
Białkowski, Je̜drzej, (2022)
- More ...
-
The signaling effects of the US food and drug administration fast-track designation
Miller, Kathleen L., (2017)
-
Market timing by Canadian bond funds
Pink, George H., (1989)
-
Government restriction on foreign investment by pension funds : an empirical evaluation
Pink, George H., (1989)
- More ...